Back
Catalyst Pharmaceuticals Stock Price Chart
BRICS Plans to End US Dollar Dominance
Learn More
Buy
53
CPRX
Catalyst Pharmaceuticals
Last Price:
20.22
Seasonality Move:
-9.33%
7 Day Trial
ALL ACCESS PASS
$
7
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing slight selling pressure.
Catalyst Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.79 | Buy |
| 20-day SMA: | 20.09 | Buy |
| 50-day SMA: | 18.31 | Buy |
| 200-day SMA: | 16.03 | Buy |
| 8-day EMA: | 19.91 | Buy |
| 20-day EMA: | 19.68 | Buy |
| 50-day EMA: | 18.62 | Buy |
| 200-day EMA: | 16.38 | Buy |
Catalyst Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.41 | Buy |
| Relative Strength Index (14 RSI): | 60.16 | Buy |
| Chaikin Money Flow: | -187954 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.41 - 20.45) | Buy |
| Bollinger Bands (100): | (15.08 - 18.84) | Buy |
Catalyst Pharmaceuticals Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Catalyst Pharmaceuticals Stock
Is Catalyst Pharmaceuticals Stock a Buy?
- Catalyst Pharmaceuticals share price is 20.22 while CPRX 8-day simple moving average is 19.79, which is a Buy signal.
- The stock price of CPRX is 20.22 while Catalyst Pharmaceuticals 20-day SMA is 20.09, which makes it a Buy.
- Catalyst Pharmaceuticals 50-day simple moving average is 18.31 while CPRX share price is 20.22, making it a Buy technically.
- CPRX stock price is 20.22 and Catalyst Pharmaceuticals 200-day simple moving average is 16.03, creating a Buy signal.
CPRX Technical Analysis vs Fundamental Analysis
Buy
53
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals a Buy or a Sell?
-
Catalyst Pharmaceuticals stock is rated a Buy
The current Catalyst Pharmaceuticals [CPRX] share price is $20.22. The Score for CPRX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Catalyst Pharmaceuticals Stock Info
Market Cap:
2.4B
Price in USD:
20.22
Share Volume:
736.65K
Catalyst Pharmaceuticals 52-Week Range
52-Week High:
20.87
52-Week Low:
11.55
Buy
53
Catalyst Pharmaceuticals (CPRX)
is a Buy
Catalyst Pharmaceuticals Share Price Forecast
-
What is the Catalyst Pharmaceuticals stock price today?
The Catalyst Pharmaceuticals stock price is 20.22 USD today. -
Will CPRX stock go up or go down?
Catalyst Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Catalyst Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Catalyst Pharmaceuticals is not overvalued.
Is Catalyst Pharmaceuticals Stock a Buy?
- Catalyst Pharmaceuticals share price is 20.22 while CPRX 8-day exponential moving average is 19.91, which is a Buy signal.
- The stock price of CPRX is 20.22 while Catalyst Pharmaceuticals 20-day EMA is 19.68, which makes it a Buy.
- Catalyst Pharmaceuticals 50-day exponential moving average is 18.62 while CPRX share price is 20.22, making it a Buy technically.
- CPRX stock price is 20.22 and Catalyst Pharmaceuticals 200-day simple moving average is 16.38, creating a Buy signal.
Fundamental Analysis of Catalyst Pharmaceuticals
Is Catalyst Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.10 per share, an increase this year of $0.05 per share, and an increase next year of $0.20 per share.
Technical Analysis of Catalyst Pharmaceuticals
Should I short Catalyst Pharmaceuticals stock?
- CPRX Moving Average Covergence Divergence (MACD) indicator is 0.41, suggesting Catalyst Pharmaceuticals is a Buy
- Catalyst Pharmaceuticals Relative Strength Index (RSI) is 60.16, which suggest Catalyst Pharmaceuticals is overbought
- The Bollinger Bands (25) for Catalyst Pharmaceuticals is (19.41 - 20.45), which suggest Catalyst Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Catalyst Pharmaceuticals is (15.08 - 18.84), which suggest Catalyst Pharmaceuticals is a Buy
* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.